Insights into Newly Approved Drugs from a Medicinal Chemistry Perspective / Elys Juliane Cardoso Lima, Renan Augusto Gomes, Evelin Fornari, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
The development of new drugs is becoming notably harder each decade. To overcome the present pitfalls in the drug development pipeline, such as those related to potency, selectivity, or absorption, distribution, metabolism, excretion and toxicity properties, medicinal chemistry strategies need to be in continuous evolution and need to become even more multidisciplinary. In this review, we present how structure-based, ligand-based, and fragment-based drug design (SBDD, LBDD, and FBDD, respectively) and their respective techniques were used for the design and optimization of successful cases of New Molecular Entities (NMEs) approved by the Food and Drug Administration (FDA).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Mini-reviews in ... medicinal chemistry - 21(2021), 16, Seite 2227- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lima, Elys Juliane Cardoso [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (22 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL00898462X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL00898462X | ||
| 003 | DE-627 | ||
| 005 | 20231128160509.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220316s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL00898462X | ||
| 035 | |a (KFL)prod_DARH_.98CFFEA32D829F13FE299BB6E5697F132DD5BB5B | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Lima, Elys Juliane Cardoso |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Insights into Newly Approved Drugs from a Medicinal Chemistry Perspective |c Elys Juliane Cardoso Lima, Renan Augusto Gomes, Evelin Fornari, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (22 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The development of new drugs is becoming notably harder each decade. To overcome the present pitfalls in the drug development pipeline, such as those related to potency, selectivity, or absorption, distribution, metabolism, excretion and toxicity properties, medicinal chemistry strategies need to be in continuous evolution and need to become even more multidisciplinary. In this review, we present how structure-based, ligand-based, and fragment-based drug design (SBDD, LBDD, and FBDD, respectively) and their respective techniques were used for the design and optimization of successful cases of New Molecular Entities (NMEs) approved by the Food and Drug Administration (FDA) | ||
| 700 | 1 | |a Gomes, Renan Augusto |e verfasserin |4 aut | |
| 700 | 1 | |a Fornari, Evelin |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva Emery, Flavio |e verfasserin |4 aut | |
| 700 | 1 | |a Trossini, Gustavo Henrique Goulart |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mini-reviews in ... medicinal chemistry |d Hilversum, the Netherlands [u.a.] : Bentham Science Publ., 2001 |g 21(2021), 16, Seite 2227- |h Online-Ressource |w (DE-627)KFL000006394 |w (DE-600)2104083-7 |w (DE-576)273887203 |x 1875-5607 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:16 |g pages:2227- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1389-5575&volume=21&issue=16&spage=2227 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_DARH_02 | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 16 |h 2227- | ||